<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04892966</url>
  </required_header>
  <id_info>
    <org_study_id>TRACK_GA</org_study_id>
    <nct_id>NCT04892966</nct_id>
  </id_info>
  <brief_title>TXI for the Recognition of Adenomas in Colonoscopy</brief_title>
  <acronym>TRACK</acronym>
  <official_title>Texture and Color Enhancement Imaging (TXI) Versus Standard White-light (WLI) Colonoscopy for Colorectal Adenoma Detection: a Multicenter, Randomized, Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This two parallel arms, randomized, multicenter trial is aimed at evaluating whether TXI is&#xD;
      superior to WLI endoscopy in terms of adenoma detection. Secondary aims will be advanced&#xD;
      adenoma detection rate, serrated polyp/adenoma detection rate, as well as procedure variables&#xD;
      such as withdrawal time.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adenoma Detection Rate (ADR)</measure>
    <time_frame>1 year</time_frame>
    <description>the proportion of participants with at least one adenoma (per-patient analysis)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Advanced ADR</measure>
    <time_frame>1 year</time_frame>
    <description>as the proportion of participants with at least one advanced adenoma at a per-patient analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>polyps, adenomas, advanced adenomas and Sessile Serrated Polyps (SSP) per subject</measure>
    <time_frame>1 year</time_frame>
    <description>the total number of detected lesions in each group divided by the total number of participants (per polyp analysis)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proximal and flat adenomas detection rate</measure>
    <time_frame>1 year</time_frame>
    <description>the total number of detected lesions in each group divided by the total number of participants (per-polyp analysis)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Withdrawal time</measure>
    <time_frame>1 year</time_frame>
    <description>Time from the start of the inspection at the cecum and the withdrawal of the colonoscope from the body of the patient.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Colorectal Polyp</condition>
  <arm_group>
    <arm_group_label>TXI (TXI group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm undergoing normal colonoscopy with TXI light</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WLI (White Light Imaging Group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arm undergoing normal colonoscopy with standard white light</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>TXI Light Imaging</intervention_name>
    <description>Standard Colonoscopy using TXI imaging</description>
    <arm_group_label>TXI (TXI group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>WLI Imaging</intervention_name>
    <description>Standard Colonoscopy using White Light Imaging</description>
    <arm_group_label>WLI (White Light Imaging Group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
        - All &gt;40 years-old patients undergoing a colonoscopy for primary screening, Faecal&#xD;
        Immunochemical Test (FIT) +, post-polypectomy surveillance&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  patients with personal history of colorectal cancer (CRC), or Inflammatory Bowel&#xD;
             Disease (IBD).&#xD;
&#xD;
          -  Patients affected with Lynch syndrome or Familiar Adenomatous Polyposis.&#xD;
&#xD;
          -  patients with inadequate bowel preparation (defined as Boston Bowel Preparation Scale&#xD;
             &lt;2 in any colonic segment).&#xD;
&#xD;
          -  patients with previous colonic resection.&#xD;
&#xD;
          -  patients on antithrombotic therapy, precluding polyp resection.&#xD;
&#xD;
          -  patients who were not able or refused to give informed written consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Giulio Antonelli</last_name>
    <phone>+393391973276</phone>
    <email>giulio.antonelli@uniroma1.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ospedale Dei Castelli</name>
      <address>
        <city>Ariccia</city>
        <state>Rome</state>
        <zip>00040</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giulio Antonelli, MD</last_name>
      <phone>+393391973276</phone>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2021</study_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Giulio Antonelli</investigator_full_name>
    <investigator_title>MD, Consultant Gastroenterologist, PhD Student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

